Across the Middle East and Eurasia, diagnostics is entering a decisive new phase — driven by rising testing demand, chronic disease burdens, and a strong push toward connected, value‑based care. Laboratories and clinics are under increasing pressure to deliver faster, smarter, and more standardized results while keeping costs and staffing under control.

At Expomed Eurasia 2026 in Istanbul, Türkiye, Ozelle GmbH will present its vision for this new era: AI‑powered hematology machine for scenario‑ready diagnostics. Founded in 2014 in a Silicon Valley laboratory and now operating globally from Frankfurt, Ozelle develops AI‑ and IoT‑enabled diagnostic systems that turn complex biological data into actionable clinical insights for human and veterinary markets.

Rethinking the Hematology Machine for the Region

Traditional hematology machine have long focused on basic Complete Blood Count (CBC) parameters, often relying on impedance technology and manual smear review for morphology. This can be slow, operator‑dependent, and difficult to standardize across multi‑site laboratory networks.

Ozelle’s latest hematology platforms go beyond the numbers. By combining CBC with high‑resolution cell imaging and AI‑driven interpretation, they enable Complete Blood Morphology (CBM) on routine samples — revealing not just how many cells are present, but also what they look like and what their morphology may indicate clinically. From infection and inflammation to anemia patterns and bone marrow response, deeper insight becomes available within minutes, without adding manual workload.

“Our goal is not to replace hematology experts, but to make expert‑level morphology accessible to every lab, every clinic, every day,” notes Ozelle’s R&D leadership.

From Hospitals to Pharmacies: Scenario‑Ready Hematology

Ozelle’s hematology machines are built to empower regional hospitals, private laboratories, GP practices, and pharmacies with advanced yet easy‑to‑use diagnostics.

I vantaggi principali includono:

• AI‑Powered, Smarter Diagnosis Advanced image‑based analysis delivering 7‑diff CBC with morphology, identifies abnormal cells with lab‑grade precision, and provides AI‑assisted interpretive flags in about six minutes per sample.
• All‑in‑One, Scenario‑Ready Testing Selected platforms integrate hematology with immunoassay and dry biochemistry, enabling combined panels such as CBC + CRP/SAA for infection, CBC + HbA1c for diabetes, or CBC + cardiac markers — all on a single compact system.
• Simple Operation and Low Maintenance One‑click, fully automatic workflows, single‑use reagent kits, room‑temperature storage, and maintenance‑free design reduce pre‑analytics, service requirements, and infrastructure barriers, making advanced hematology feasible even in decentralized or resource‑constrained settings.

In Türkiye and across the wider Middle East and Eurasia, governments and private hospital groups are rapidly expanding diagnostic lab capacity, upgrading networks and adopting more advanced in‑vitro diagnostics and automated analyzers. In this context of rising test volumes and growing chronic disease burdens, AI‑powered hematology machine turn macro trends into everyday value for providers by increasing diagnostic capacity, shortening turnaround times and improving result consistency across dispersed care networks.

Hematology Machine as Part of an Intelligent Ecosystem

Beyond hardware, Ozelle is building an intelligent hematology ecosystem that combines AI‑powered analyzers, an embedded Intelligent AI Workbench (Open Dx), and a cloud‑ready IoT platform into one continuous workflow. Inside the analyzer, the AI Workbench unifies test ordering, real‑time result visualization, high‑resolution cell images, and AI‑assisted interpretation — transforming static CBC and morphology reports into interactive, guidance‑driven insights for clinicians and veterinarians. On the connectivity layer, CBC and morphology results can be integrated into LIS/HIS, streamed via LAN/Wi‑Fi, and linked to Ozelle’s Smart IoT and Operations Management platforms for multi‑site device monitoring, consumables tracking, sample management and BI analytics.

For importers, distributors, and group hospital customers, hematology machines are no longer isolated boxes on the bench, but intelligent nodes in a data‑driven diagnostic network. This ecosystem approach supports scalable, standardized blood testing, enables remote supervision and AI‑assisted report consultation, and aligns with long‑term ambitions around digital health, smart hospitals and tele‑hematology.

What Ozelle Will Showcase at Expomed Eurasia 2026

At Expomed Eurasia 2026, Ozelle GmbH will be onsite at Hall 8, Booth 861B in the laboratory & diagnostics section, presenting an integrated AI × CBM diagnostic system that combines multi‑functional analyzers, image‑based hematology and the built‑in Intelligent AI Workbench (Open Dx) into one end‑to‑end workflow for human and veterinary care. Visitors will be able to experience how hardware, software and AI work together across three flagship analyzers:

Multi‑Functional Analyzer EHBT‑50 Mini Lab

The EHBT‑50 Mini Lab is a compact 7‑diff multi‑functional analyzer that integrates CBC, immunofluorescence and dry biochemistry in a single platform, powered by Ozelle’s AI × CBM engine and the embedded AI Workbench. Rather than acting as a standalone hematology device, EHBT‑50 Mini Lab functions as a mini‑lab console where clinicians can configure scenario‑ready panels (e.g. infection, diabetes, emergency assessments), review numerical parameters and high‑resolution cell images, and receive AI‑assisted summaries and guidance — all within one unified interface. Single‑use cartridges, room‑temperature reagents and a maintenance‑free design make it ideal for hospitals, diagnostic centers and high‑end clinics that want to consolidate multiple instruments into an intelligent, all‑in‑one workstation.

Auto Hematology Analyzer EHBT‑75

The EHBT‑75 is a high‑throughput 7‑diff auto hematology analyzer built on image‑based AI and Complete Blood Morphology (CBM), delivering 41 parameters with detailed morphology flags and high‑resolution cell images. Inside the analyzer, the integrated AI Workbench (Open Dx) brings test ordering, real‑time result visualization and AI‑assisted interpretation into a single digital layer — turning EHBT‑75 from a pure cell counter into an interactive diagnostic console for routine hospital and reference lab workflows. Designed to standardize results across laboratory networks, reduce manual smear review and surface clear, structured interpretations, EHBT‑75 shows how AI × CBM can deliver expert‑level morphology insight with central‑lab efficiency.

Multi‑Functional Analyzer for Vet EHVT‑50

The EHVT‑50 is a veterinary multi‑functional analyzer that combines 7‑diff hematology, immunofluorescence, urine sediment and fecal testing for companion animals, built on the same AI × CBM architecture and AI Workbench layer as the human portfolio. Within a single compact system, veterinary teams can run blood, urine and feces tests for dogs, cats and other species, then use the integrated workbench to view species‑specific parameters, morphology images and AI‑assisted diagnostic notes and medication references tailored to animal care. This allows animal hospitals and clinics to move from fragmented in‑house and send‑out testing to a unified, intelligent diagnostic workflow.

Together, these three platforms demonstrate that Ozelle is not just selling analyzers, but delivering a connected AI × CBM ecosystem — where multi‑modal testing, embedded AI Workbench software and cloud‑ready connectivity work as one system to support smarter, more standardized decisions across human hospitals, clinics and veterinary settings.

Meet Ozelle at Expomed Eurasia 2026

Event: Expomed Eurasia 2026 Dates: April 16–18, 2026 Venue: Tüyap Fair and Congress Center, Istanbul, Türkiye Location: Hall 8, Booth 861B – Ozelle GmbH

At Hall 8, Booth 861B, Ozelle will showcase its next‑generation hematology machines and AI‑powered diagnostic solutions, from compact multi‑functional EHBT‑50 Mini Lab to compact analyzer EHBT‑75 and veterinary EHVT‑50, all built on AI‑based Complete Blood Morphology (CBM). Visitors are invited to experience live demonstrations, explore real‑world testing scenarios, and discuss partnership opportunities for Türkiye, the Middle East and the wider Eurasia region.

To learn more about Ozelle at Expomed Eurasia and view the official exhibitor profile, please visit website:www.ozellemed.com

Save the date — and be among the first to experience how AI‑driven hematology from Ozelle can help you see beyond the blood and unlock the next level of diagnostic insight at Expomed Eurasia 2026.